BOSTON SCIENTIFIC CORPORATION Assets, Fair Value Disclosure
BOSTON SCIENTIFIC CORPORATION (BSX) had Assets, Fair Value Disclosure of $475.00 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:AssetsFairValueDisclosure · last filed 2026-08-03
- 2026-06-30: Assets, Fair Value Disclosure $475.00M.
- 2026-03-31: Assets, Fair Value Disclosure $919.00M.
- 2025-12-31: Assets, Fair Value Disclosure $1.27B.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2026-06-30 | $475.00M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $919.00M 10-Q · filed 2026-05-01 |
| 2025-12-31 | $1.27B 10-Q · filed 2026-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |